drugset / Trial / NCT00204737

Short Course Glucocorticoid Treatment for PTSD

NCT00204737 ↗

Phase 4 Completed 12 enrolled University of Wisconsin, Madison
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo

Timeline

Start
2004-12
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified 20 mg Oral